Cargando…

Disclosures

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	Disclosures
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147390/ http://dx.doi.org/10.1097/GOX.0000000000001055

Ejemplares similares

Conflict of Interest Disclosures
Publicado: (2017)

Conflict of Interest Disclosures
Publicado: (2018)

Conflict of Interest Disclosures
Publicado: (2019)

Conflict of Interest Disclosures
Publicado: (2021)

Conflict of Interest Disclosures
Publicado: (2022)

Conflict of Interest Disclosures
Publicado: (2023)

MTX-13, a Novel PTK7-Directed Antibody–Drug Conjugate with Widened Therapeutic Index Shows Sustained Tumor Regressions for a Broader Spectrum of PTK7-Positive Tumors
por: Kong, Chao, et al.
Publicado: (2023)

Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer
por: Toader, Dorin, et al.
Publicado: (2023)

AMT-562, a Novel HER3-targeting Antibody–Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing Tumors
por: Weng, Weining, et al.
Publicado: (2023)

Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers
por: Zhou, Wei, et al.
Publicado: (2023)

A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer
por: Deng, Jiaojiao, et al.
Publicado: (2021)

Datopotamab Deruxtecan, a Novel TROP2-directed Antibody–drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells
por: Okajima, Daisuke, et al.
Publicado: (2021)

TPX-0131, a Potent CNS-penetrant, Next-generation Inhibitor of Wild-type ALK and ALK-resistant Mutations
por: Murray, Brion W., et al.
Publicado: (2021)

RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors
por: Roulston, Anne, et al.
Publicado: (2022)

Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor Activity
por: Brehmer, Dirk, et al.
Publicado: (2021)

Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages
por: Smith, Bryan D., et al.
Publicado: (2021)

A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies
por: Zimmermann, Astrid, et al.
Publicado: (2022)

Anticancer Activity of ST101, A Novel Antagonist of CCAAT/Enhancer Binding Protein β
por: Darvishi, Emad, et al.
Publicado: (2022)

BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors
por: Rigby, Michael, et al.
Publicado: (2022)

Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers
por: Li, Xiaofan, et al.
Publicado: (2023)

Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic
por: Rossmueller, Gregor, et al.
Publicado: (2023)

SGN-CD228A Is an Investigational CD228-Directed Antibody–Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models
por: Mazahreh, Rebecca, et al.
Publicado: (2023)

Disclosure of responsible information by Spanish local governments
por: Pache-Durán, María, et al.
Publicado: (2019)

Disclosures Undisclosed
por: Janney, Cory F., et al.
Publicado: (2019)

Clarification of Disclosure
Publicado: (2022)

Disclosure of Sexual Victimization: Effects of Invalidation and Shame on Re-Disclosure
por: Catton, Ashley K. H., et al.
Publicado: (2023)

(Non-)disclosure of lifetime sexual violence in maternity care: Disclosure rate, associated characteristics and reasons for non-disclosure
por: de Klerk, Hannah W., et al.
Publicado: (2023)

Financial disclosure quality and sustainability disclosure quality. A case in China
por: Abeysekera, Indra, et al.
Publicado: (2021)

A Disclosure About Death Disclosure: Variability in Circulatory Death Determination
por: Robinson, Christopher P., et al.
Publicado: (2021)

Full Disclosure Policy
por: Goehl, TJ
Publicado: (2003)

Biographic and Disclosure Information
Publicado: (2012)

Biographic and Disclosure Information
Publicado: (2012)

Biographic and Disclosure Information
Publicado: (2012)

Biographic and Disclosure Information
Publicado: (2013)

Biographic and disclosure information
Publicado: (2013)

Biographic and disclosure information
Publicado: (2012)

Authorship and contribution disclosures
por: Sauermann, Henry, et al.
Publicado: (2017)

Patient Safety and Disclosure
por: Viale, Pamela Hallquist
Publicado: (2019)

Disclosure and Data Linkage
por: Turner, Andrew, et al.
Publicado: (2017)

Prophesies and Disclosures in Dreams
Publicado: (1886)

Cannot write session to /tmp/vufind_sessions/sess_tdu59ld84306li5ebo321hdgag